Sutro Biopharma (STRO) Revenue (QoQ) (2017 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Revenue (QoQ) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 334.66 Mn | 170.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -31.91% |
| Sep 30, 2025 | -84.79% |
| Jun 30, 2025 | 266.37% |
| Mar 31, 2025 | 17.49% |
| Dec 31, 2024 | 73.81% |
| Sep 30, 2024 | -66.86% |
| Jun 30, 2024 | 97.62% |
| Mar 31, 2024 | -88.56% |
| Dec 31, 2023 | 571.95% |
| Sep 30, 2023 | 62.54% |
| Jun 30, 2023 | -17.85% |
| Mar 31, 2023 | 46.83% |
| Dec 31, 2022 | -65.67% |
| Sep 30, 2022 | -10.50% |
| Jun 30, 2022 | 376.45% |
| Mar 31, 2022 | -44.65% |
| Dec 31, 2021 | 25.09% |
| Sep 30, 2021 | -69.64% |
| Jun 30, 2021 | 91.33% |
| Mar 31, 2021 | 77.10% |